Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study.

Conclusions: Drug-induced osteonecrosis has a low incidence in Mexican population, denosumab does not show a greater number of cases of osteonecrosis compared to bisphosphonates; no association was found between functional status, number of metastatic bone sites, nor use of antigenic or tyrosine kinase inhibitors as factor associated with osteonecrosis of the jaws. PMID: 31264983 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31264983?dopt=Abstract

Source: Cirugia y Cirujanos - July 4, 2019 Category: Surgery Authors: Chaurand-Lara J, Pacheco-Ruiz L, Trejo-Campos JL, Facio-Umaña JA, Mora-Pérez J Tags: Cir Cir Source Type: research